NASDAQ: AZN
Astrazeneca Plc Stock

Overview

Forecast Earnings Dividend Ownership

AZN Price

$50.86

Fair Value Price

N/A

Market Cap

$133.46B

52 Week Low

$36.15

52 Week High

$64.94

P/E

53.54x

P/B

10.94x

P/S

5.56x

PEG

0.81x

Dividend Yield

2.75%

Revenue

$25.87B

Earnings

$2.42B

Gross Margin

80.1%

Operating Margin

16.72%

Profit Margin

9.3%

Debt to Equity

4.14

Operating Cash Flow

$4B

Beta

0.62

Next Earnings

N/A

Ex-Dividend

N/A

Next Dividend

N/A

Zen Score

Expand Score

High

Medium

Low

Industry average

Reasons for this score

AZN ($50.86) is trading below its intrinsic value of $207.32, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"

Valuation

AZN is poor value based on its earnings relative to its share price (53.54x), compared to the US market average (40.05x)

Valuation

AZN is good value based on its earnings relative to its share price (53.54x), compared to the US Drug Manufacturers - General industry average (-4.33x)

Valuation

AZN News

Valuation

AZN price to earnings (PE)

For valuing profitable companies with steady earnings

Company

53.54x

Industry

-4.33x

Market

40.05x

AZN is poor value based on its earnings relative to its share price (53.54x), compared to the US market average (40.05x)

Valuation

AZN is good value based on its earnings relative to its share price (53.54x), compared to the US Drug Manufacturers - General industry average (-4.33x)

Valuation

AZN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company

10.94x

Industry

8.46x

Market

36.62x

AZN is good value based on its book value relative to its share price (10.94x), compared to the US market average (36.62x)

Valuation

AZN is poor value based on its book value relative to its share price (10.94x), compared to the US Drug Manufacturers - General industry average (8.46x)

Valuation

AZN price to earnings growth (PEG)

For valuing profitable companies with growth potential

AZN is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.81x)

Valuation

AZN's financial health

Profit margin

Revenue

$6.6B

Net Income

$651.0M

Profit Margin

9.9%

AZN's Earnings (EBIT) of $4.33B are insufficient to safely cover interest payments on company debt ($22.34B)

Financials

AZN's profit margin has increased (+1.2%) in the last year from (8.1%) to (9.3%)

Financials

Assets to liabilities

Assets

$64.1B

Liabilities

$50.5B

Debt to equity

1.83

AZN's short-term liabilities ($18.94B) exceed its short-term assets ($18.17B)

Financials

AZN's long-term liabilities ($31.55B) exceed its short-term assets ($18.17B)

Financials

AZN's debt has increased relative to shareholder equity (4.14), over the past 5 years ago (2.12)

Financials

AZN's debt to equity ratio (4.14) is considered high

Financials

Cash flow

Operating

$1.8B

Investing

-$580.0M

Financing

$1.2B

AZN's operating cash flow ($4.38B) may not be sufficient to safely service the company's debt ($22.34B)

Financials

Astrazeneca Stock FAQ

What is Astrazeneca's quote symbol?

(NASDAQ: AZN) Astrazeneca trades on the NASDAQ under the ticker symbol AZN. Astrazeneca stock quotes can also be displayed as NASDAQ: AZN.

How much is Astrazeneca's stock price per share?

(NASDAQ: AZN) Astrazeneca stock price per share is $50.86 today (as of Jan 8, 2021).

What is the 52 week high and low for Astrazeneca (NASDAQ: AZN)?

(NASDAQ: AZN) Astrazeneca's 52-week high was $64.94, and its 52-week low was $36.15. It is currently -21.68% from its 52-week high and 40.69% from its 52-week low.

What is Astrazeneca's Market Cap?

(NASDAQ: AZN) Astrazeneca's market cap is $133.46B, as of Jan 16, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Astrazeneca's market cap is calculated by multiplying AZN's current stock price of $50.86 by AZN's total outstanding shares of 1,312,000,000.

How much is Astrazeneca stock worth today?

(NASDAQ: AZN) Astrazeneca currently has 1,312,000,000 outstanding shares. With Astrazeneca stock trading at $50.86 per share, the total value of Astrazeneca stock (market capitalization) is $133.46B.

Astrazeneca stock was originally listed at a price of $18.00 in Dec 31, 1997. If you had invested in Astrazeneca stock at $18.00, your return over the last 23 years would have been 182.56%, for an annualized return of 4.62%.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Zen Score

Reasons for this score

AZN News

Valuation

AZN price to earnings (PE)

For valuing profitable companies with steady earnings

AZN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

AZN price to earnings growth (PEG)

For valuing profitable companies with growth potential

AZN's financial health

Profit margin

Assets to liabilities

Cash flow

Astrazeneca Stock FAQ

(NASDAQ: AZN) Astrazeneca trades on the NASDAQ under the ticker symbol AZN. Astrazeneca stock quotes can also be displayed as NASDAQ: AZN.

(NASDAQ: AZN) Astrazeneca stock price per share is $50.86 today (as of Jan 8, 2021).

(NASDAQ: AZN) Astrazeneca's 52-week high was $64.94, and its 52-week low was $36.15. It is currently -21.68% from its 52-week high and 40.69% from its 52-week low.

Company

Stocks

Social